These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 16794480)
1. Deregulated expression of monocyte chemoattractant protein-1 (MCP-1) in arterial hypertension: role in endothelial inflammation and atheromasia. Tucci M; Quatraro C; Frassanito MA; Silvestris F J Hypertens; 2006 Jul; 24(7):1307-18. PubMed ID: 16794480 [TBL] [Abstract][Full Text] [Related]
2. Acute inflammatory reactions caused by histamine via monocytes/macrophages chronically participate in the initiation and progression of atherosclerosis. Kimura S; Wang KY; Tanimoto A; Murata Y; Nakashima Y; Sasaguri Y Pathol Int; 2004 Jul; 54(7):465-74. PubMed ID: 15189499 [TBL] [Abstract][Full Text] [Related]
3. Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder. Vázquez-Lavista LG; Lima G; Gabilondo F; Llorente L Urology; 2009 Aug; 74(2):414-8. PubMed ID: 19646633 [TBL] [Abstract][Full Text] [Related]
4. Increased levels of atherosclerosis markers in salt-sensitive hypertension. Larrousse M; Bragulat E; Segarra M; Sierra C; Coca A; de La Sierra A Am J Hypertens; 2006 Jan; 19(1):87-93. PubMed ID: 16461197 [TBL] [Abstract][Full Text] [Related]
5. MCP-1 chemokine receptor CCR2 is decreased on circulating monocytes in sporadic amyotrophic lateral sclerosis (sALS). Zhang R; Gascon R; Miller RG; Gelinas DF; Mass J; Lancero M; Narvaez A; McGrath MS J Neuroimmunol; 2006 Oct; 179(1-2):87-93. PubMed ID: 16857270 [TBL] [Abstract][Full Text] [Related]
6. Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis. Tucci M; Barnes EV; Sobel ES; Croker BP; Segal MS; Reeves WH; Richards HB Arthritis Rheum; 2004 Jun; 50(6):1842-9. PubMed ID: 15188361 [TBL] [Abstract][Full Text] [Related]
7. Endogenous NO blockade enhances tissue factor expression via increased Ca2+ influx through MCP-1 in endothelial cells by monocyte adhesion. Sakamoto T; Ishibashi T; Sakamoto N; Sugimoto K; Egashira K; Ohkawara H; Nagata K; Yokoyama K; Kamioka M; Ichiki T; Sugimoto N; Kurabayashi M; Suzuki K; Takuwa Y; Maruyama Y Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):2005-11. PubMed ID: 16020745 [TBL] [Abstract][Full Text] [Related]
8. The influence of HIV infection on the correlation between plasma concentrations of monocyte chemoattractant protein-1 and carotid atherosclerosis. Joven J; Coll B; Tous M; Ferré N; Alonso-Villaverde C; Parra S; Camps J Clin Chim Acta; 2006 Jun; 368(1-2):114-9. PubMed ID: 16445900 [TBL] [Abstract][Full Text] [Related]
9. The environmental carcinogen benzo[a]pyrene induces expression of monocyte-chemoattractant protein-1 in vascular tissue: a possible role in atherogenesis. Knaapen AM; Curfs DM; Pachen DM; Gottschalk RW; de Winther MP; Daemen MJ; Van Schooten FJ Mutat Res; 2007 Aug; 621(1-2):31-41. PubMed ID: 17376491 [TBL] [Abstract][Full Text] [Related]
10. Elevated monocyte chemotactic proteins 1, 2, and 3 in pulmonary alveolar proteinosis are associated with chemokine receptor suppression. Bonfield TL; John N; Malur A; Barna BP; Culver DA; Kavuru MS; Thomassen MJ Clin Immunol; 2005 Jan; 114(1):79-85. PubMed ID: 15596412 [TBL] [Abstract][Full Text] [Related]
11. Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study. Nahon P; Sutton A; Rufat P; Faisant C; Simon C; Barget N; Trinchet JC; Beaugrand M; Gattegno L; Charnaux N Eur J Gastroenterol Hepatol; 2007 May; 19(5):425-31. PubMed ID: 17413295 [TBL] [Abstract][Full Text] [Related]
12. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for cardiovascular disease in hemodialyzed patients. Buraczynska M; Bednarek-Skublewska A; Buraczynska K; Ksiazek A Cytokine; 2008 Dec; 44(3):361-5. PubMed ID: 19014891 [TBL] [Abstract][Full Text] [Related]
13. Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation. Kim B; Sarangi PP; Lee Y; Deshpande Kaistha S; Lee S; Rouse BT J Leukoc Biol; 2006 Dec; 80(6):1405-15. PubMed ID: 16997857 [TBL] [Abstract][Full Text] [Related]
14. Mast cell tryptase in mast cell granules enhances MCP-1 and interleukin-8 production in human endothelial cells. Kinoshita M; Okada M; Hara M; Furukawa Y; Matsumori A Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1858-63. PubMed ID: 15976326 [TBL] [Abstract][Full Text] [Related]
15. Nonendothelial mesenchymal cell-derived MCP-1 is required for FGF-2-mediated therapeutic neovascularization: critical role of the inflammatory/arteriogenic pathway. Fujii T; Yonemitsu Y; Onimaru M; Tanii M; Nakano T; Egashira K; Takehara T; Inoue M; Hasegawa M; Kuwano H; Sueishi K Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2483-9. PubMed ID: 16960104 [TBL] [Abstract][Full Text] [Related]
16. Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter region. Gilbert J; Lekstrom-Himes J; Donaldson D; Lee Y; Hu M; Xu J; Wyant T; Davidson M; Am J Cardiol; 2011 Mar; 107(6):906-11. PubMed ID: 21247529 [TBL] [Abstract][Full Text] [Related]
17. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with psoriasis. Wang L; Yang L; Gao L; Gao TW; Li W; Liu YF Int J Immunogenet; 2008 Feb; 35(1):45-9. PubMed ID: 18093183 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation. Bjerkeli V; Damås JK; Fevang B; Holter JC; Aukrust P; Frøland SS Rheumatology (Oxford); 2007 Sep; 46(9):1422-7. PubMed ID: 17616549 [TBL] [Abstract][Full Text] [Related]
19. Lack of association between monocyte protein-1 (MCP-1) -2518 A>G chemoattractant and C-C chemokine receptor 2 (CCR2) Val64Ile polymorphisms and multiple sclerosis in a Tunisian population. Messadi A; Fekih-Mrissa N; Kallel A; Bouguerra C; Sediri Y; Zaweli J; Laayouni S; Nciri B; Yedeas M; Mrissa R; Jemaa R; Kaabachi N; Gritli N J Clin Neurosci; 2010 Oct; 17(10):1311-3. PubMed ID: 20637631 [TBL] [Abstract][Full Text] [Related]
20. Effect of transdermal hormone replacement therapy on the monocyte chemoattractant protein-1 concentrations and other vascular inflammatory markers and on endothelial function in postmenopausal women. Sumino H; Ichikawa S; Ohyama Y; Takahashi T; Saito Y; Nakamura T; Kanda T; Kurabayashi M Am J Cardiol; 2005 Jul; 96(1):148-53. PubMed ID: 15979455 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]